TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hisamitsu Pharmaceutical Co ( (JP:4530) ) just unveiled an announcement.
Hisamitsu Pharmaceutical Co. announced the acquisition of 156,800 of its own shares, amounting to 674,001,100 yen, through open market purchases on the Tokyo Stock Exchange. This move is part of a broader strategy approved by the board to acquire up to 3 million shares, aiming to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:4530) stock is a Buy with a Yen4700.00 price target. To see the full list of analyst forecasts on Hisamitsu Pharmaceutical Co stock, see the JP:4530 Stock Forecast page.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc., headquartered in Tosu City, Saga Prefecture, is a company involved in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, with a significant emphasis on transdermal drug delivery systems.
Average Trading Volume: 182,838
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen313B
For an in-depth examination of 4530 stock, go to TipRanks’ Overview page.